Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07232160

Is Density Spectral Array Display Along With Bispectral Index Superior to the Display of Bispectral Index Alone

A study to evaluate the use of density spectral array display in comparison with Bispectral index in a clinical setting.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Royal Brisbane and Women's Hospital

Herston, Queensland, 4006, Australia

Location contact

Alison Mudge, PhD

SUB_INVESTIGATOR

Andre Van Zundert, PhD

SUB_INVESTIGATOR

Christine Woods

CONTACT

[email protected]

+6136468111

Jamie Sleigh, PhD

SUB_INVESTIGATOR

Victoria Eley, PhD

SUB_INVESTIGATOR

About this study

Propofol-based total intravenous anesthesia (TIVA) is a popular general anesthesia (GA) technique with an increased risk of unintended awareness under GA, which can be a devastating and life-changing complication. Age-related changes may impact the performance of EEG-derived depth of anesthesia indices in those older than 65 years, particularly in the presence of cognitive disorders.

Hypothesis: In comparison to monitor 1 (BIS only), monitor 2 (DSA + BIS) will have higher sensitivity and specificity to detect recovery

Objectives:

Investigators will prospectively measure the sensitivity and specificity of monitor 1 versus monitor 2 in patients older than 65 years receiving propofol-based TIVA.

Methods:

Investigators will recruit 70 participants from the Royal Brisbane and Women's Hospital (RBWH) who are aged 65 years or older and scheduled for elective endovascular or endoscopic urologic procedures.

Investigators aim to determine whether the display of DSA can enhance the sensitivity and specificity of depth of anesthesia monitors in detecting sudden changes in anesthetic depth in older patients. This may enhance the detection of inadequate administration or delivery of propofol and may lower the incidence of unintended awareness under general anesthesia in that age group.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 65 years undergoing elective procedures of 1-3 hours' duration requiring GA.
  • Procedures in which a DoA monitor can be applied to the forehead.
  • Patients receiving intravenous propofol and opiate anaesthesia using supraglottic airway device.
  • Patient able to provide informed consent.

Exclusion criteria

  • Administration of ketamine/dexmedetomidine.
  • Administration of inhaled anaesthetic agents or nitrous oxide
  • Administration of muscle relaxation

Treatment and study plan

Depth of anesthesia monitoring using processed EEG

Device

Comparison of processed EEG monitor (Bispectral index) with and without Density spectral array

Primary outcomes

  1. aim

    Time frame: In the perioperative period, following the cessation of anesthesia, the patient begins to emerge from a deep anesthetic state to a lighter state and then regains consciousness. The time frame is usually in minutes, but varies depending on various factors

    Sensitivity and specificity of Bispectral index combined with density spectral array compared with Bispectral index alone in detection of emergence from general anesthesia. Emergence from anaesthesia manifests in changes in the BIS and/or DSA suggestive of a change in the depth of anesthesia and progress towards regaining consciousness.

  2. Primary aim

    Time frame: In the perioperative period, time following the cessation of intravenous anesthesia after the procedure; emergence from anesthesia usually takes place over a few minutes to hours.

    Evaluate the sensitivity and specificity of Bispectral index combined with density spectral array compared with Bispectral index alone in the detection of the timing of emergence from general anesthesia.

Study contacts

Contact information is provided by the study sponsor or research team.

Michael Boules, MB BCh, FANZCA

CONTACT

[email protected]

+61450506350

Victoria Eley, PhD

CONTACT

[email protected]

+6136468111

Sponsors and collaborators

Lead sponsor

The University of Queensland

Other

Collaborators

  • Medtronic

Registry information

Official study title

Is DSA Display Along With Bispectral Index Superior to the Display of Bispectral Index Alone in Detecting Emergence From Propofol and Opiate Anesthesia? A Prospective Observational Study in Patients Older Than 65 Years?

Acronym: DSA-Light

Important dates

Study start
2026
Primary completion
2028
Study completion
2029
First posted
Nov 18, 2025
Registry last updated
Nov 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.